Home
Conditions
Ovarian Neoplasms

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,293 public trials 504 recruiting studies

Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Completed

Advanced Ovarian Cancer and Sexuality Phase 1

NCT00488202

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations: UBC Sexual Health Lab, Vancouver Hospital Vancouver, British Columbia, Canada

UBC Sexual Health Lab Vancouver, British Columbia, Canada

View Trial Details

Completed

Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer

NCT01679483

Conditions: Adnexal Diseases, Cervical Cancer, Endocrine Gland Neoplasms, +22 more
Locations: Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center Seoul, South Korea

View Trial Details

Completed

Hysterectomy for Benign Gynaecological Conditions With or Without Tubectomy

NCT02281487

Conditions: Abdominal Hysterectomy (& Wertheim), Adnexal Diseases, Endocrine Gland Neoplasms, +13 more
Locations: Radboudumc Nijmegen, Gelderland, Netherlands

Jeroen Bosch ziekenhuis 's-Hertogenbosch, North Brabant, Netherlands

Catharina Ziekenhuis Eindhoven, North Brabant, Netherlands

Elisabeth ziekenhuis Tilburg, North Brabant, Netherlands

View Trial Details

Completed

Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer

NCT00337233

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +26 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT01175343

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
Locations: Tower Cancer Research Foundation Beverly Hills, California, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

Los Angeles County-USC Medical Center Los Angeles, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Completed

Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)

NCT01684878

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Tiroler Landeskrankenanstalten Ges.M.B.H.; Abt. Für Gynäkologie Innsbruck, Austria

Medizinische Universität Wien; Univ.Klinik für Frauenheilkunde - Klinik für Gynäkologie Vienna, Austria

UZ Leuven Gasthuisberg Leuven, Belgium

Herlev Hospital; Onkologisk afdeling Herlev, Denmark

View all 68 locations

View Trial Details

Completed

Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer

NCT01778803

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Florida Cancer Specialists Sarasota, Florida, United States

University of Oklahoma Oklahoma City, Oklahoma, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View Trial Details

Completed

A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed

NCT00097019

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625)

NCT00780039

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

A Trial to Evaluate Efficacy and Safety of the Combination Therapy of Genexol®-PM Plus Carboplatin® Compared to Genexol® Plus Carboplatin® as a Firstline Treatment in Subjects With Ovarian Cancer

NCT01276548

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Asan Medical Center Seoul, Songpa-gu, Pungnap-2 Dong, South Korea

View Trial Details

Ovarian Neoplasms

Ovarian Neoplasms trial results

Related conditions